Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00594672 · ClinicalTrials.gov registry record

Age-Related Eye Disease Study (AREDS) Follow-Up

A clinical trial of Cataract and Age-related Macular Degeneration, sponsored by National Eye Institute (NEI).

Active
Registry status
110
Enrollment target
1
Study location

NCT00594672 is a study of Cataract and Age-related Macular Degeneration that is active but no longer recruiting, run by National Eye Institute (NEI). The registered enrollment target is 110 participants, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00594672, a study of Cataract and Age-related Macular Degeneration, is active but no longer recruiting, sponsored by National Eye Institute (NEI).

ACTIVE NOT RECRUITING
Registry status
110 participants
Enrollment target
1
Study location

Study Summary

This study is a 5-year extension of the AREDS protocol, in which investigators followed the natural course of age-related macular degeneration (AMD) and cataracts. Participants in the former AREDS protocol are eligible for this study. Participants have a complete eye examination once a year and are contacted at least once a year between visits to check on their status. The eye examination includes measurement of visual acuity (vision chart test) and examination of the inside of the eye after the pupils have been dilated with eye drops. Photographs of the inside of the eye may be taken using a special camera that flashes a bright light in the eye. A blood sample may be obtained to test for cholesterol level and genes related to inflammation....

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2008-06-02

Sponsor

National Eye Institute (NEI)

221 total trials

What the Registry Record Tells You About NCT00594672

The ClinicalTrials.gov registry entry for NCT00594672 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (52% lower). The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cataract appearing as the primary indexed condition, and to 0 interventions.

NCT00594672 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00594672 about?

NCT00594672 is a clinical study titled "Age-Related Eye Disease Study (AREDS) Follow-Up". This study is a 5-year extension of the AREDS protocol, in which investigators followed the natural course of age-related macular degeneration (AMD) and cataracts. Participants in the former AREDS protocol are eligible for this study. Participants have a complete eye examination once a year and are...

What is the current status of trial NCT00594672?

This trial is currently active not recruiting. The enrollment target is 110 participants. The study started on 2008-06-02.

What conditions does trial NCT00594672 study?

This clinical trial studies the following conditions: Cataract, Age-related Macular Degeneration.

Who is sponsoring clinical trial NCT00594672?

This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00594672 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.